NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma. White MC, Lange PT, Stewart J, Damania B, et al. Proc Natl Acad Sci U S A 2026;123:e2535550123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

White MC, Lange PT, Stewart J, Damania B, et al. NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma. Proc Natl Acad Sci U S A 2026;123:e2535550123.
PMID: 42133805